Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -68.96% is 94% below its 5-year average of -35.57%, near the low end of its 5-year range (-68.96%–-16.76%).
79.51% below its 12-month average of -38.41%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -34.13%.
RETURN ON ASSETS (ROA)
-68.96%
RETURN ON ASSETS (ROA) AVG TTM
-38.41%
RETURN ON ASSETS (ROA) AVG 3Y
-33.02%
RETURN ON ASSETS (ROA) AVG 5Y
-35.57%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-79.51%
CURRENT VS 3Y AVG
-108.84%
CURRENT VS 5Y AVG
-93.85%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-113.73%
vs the sector median at left
Alpha Tau Medical Ltd
Market Cap
$1.31B
Return on Assets (ROA)
-68.96%
TTM Avg
-38.41%
3Y Avg
-33.02%
5Y Avg
-35.57%
Market Cap
$1.33B
Return on Assets (ROA)
-32.81%
TTM Avg
-32.81%
3Y Avg
-32.81%
5Y Avg
-32.81%
Market Cap
$1.34B
Return on Assets (ROA)
43.52%
TTM Avg
-28.82%
3Y Avg
-20.19%
5Y Avg
-30.60%
Market Cap
$1.37B
Return on Assets (ROA)
-89.60%
TTM Avg
418.97%
3Y Avg
177.41%
5Y Avg
100.38%
Market Cap
$1.24B
Return on Assets (ROA)
-34.68%
TTM Avg
-39.07%
3Y Avg
-38.32%
5Y Avg
-34.05%
Market Cap
$1.23B
Return on Assets (ROA)
1.31%
TTM Avg
-17.71%
3Y Avg
-26.67%
5Y Avg
-26.67%
Market Cap
$1.23B
Return on Assets (ROA)
5.91%
TTM Avg
1.36%
3Y Avg
-4.42%
5Y Avg
-8.30%
Market Cap
$1.39B
Return on Assets (ROA)
3.12%
TTM Avg
3.19%
3Y Avg
2.54%
5Y Avg
2.30%
Market Cap
$1.22B
Return on Assets (ROA)
-0.46%
TTM Avg
-2.95%
3Y Avg
-4.25%
5Y Avg
-4.39%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Tau Medical Ltd (DRTS) | $1.31B | -68.96% | -38.41% | -33.02% | -35.57% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.33B | -32.81% | -32.81% | -32.81% | -32.81% |
| Omeros Corporation (OMER)vs › | $1.34B | 43.52% | -28.82% | -20.19% | -30.60% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.37B | -89.60% | 418.97% | 177.41% | 100.38% |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | -34.68% | -39.07% | -38.32% | -34.05% |
| Omada Health (OMDA)vs › | $1.23B | 1.31% | -17.71% | -26.67% | -26.67% |
| Cronos Group Inc. (CRON)vs › | $1.23B | 5.91% | 1.36% | -4.42% | -8.30% |
| The Pennant Group, Inc. (PNTG)vs › | $1.39B | 3.12% | 3.19% | 2.54% | 2.30% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | -0.46% | -2.95% | -4.25% | -4.39% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.40B | N/A | N/A | N/A | N/A |
ROA
-69.0%
ROE
-210.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -40.00% |
| 2024-12-31 | -36.83% |
| 2023-12-31 | -27.15% |
| 2022-12-31 | -28.10% |
| 2021-12-31 | -64.60% |
| 2020-12-31 | -16.76% |
| 2019-12-31 | -26.82% |
